Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-02-28 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-RAMBERT-D'ALBON (26140), Drome
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE RAMBERTOISE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE RAMBERTOISE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-RAMBERT-D'ALBON (26140),
this company of category PME
shows in 2025 a net income positive of 88 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE RAMBERTOISE (SIREN 827994013)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
87 708 €
49 910 €
170 864 €
239 109 €
171 011 €
157 841 €
118 954 €
27 324 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, GRANDE PHARMACIE RAMBERTOISE generates positive net income of 88 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 27 k€ -> 88 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
87 708 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 201%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
200.759%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.723%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE RAMBERTOISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1905.996
1014.665
519.953
322.267
191.99
144.475
228.319
200.759
Financial autonomy
4.497
8.125
14.506
21.588
30.451
36.219
27.165
29.723
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
200.762025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+6 pts over 3 years
In 2025, the debt ratio of GRANDE PHARMACIE RAMBERTOISE (200.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.72%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-10 pts over 3 years
In 2025, the financial autonomy of GRANDE PHARMACIE RAMBERTOISE (29.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 121.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
121.515
Liquidity indicators evolution GRANDE PHARMACIE RAMBERTOISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
176.6
166.255
142.216
164.991
56.232
47.343
128.416
121.515
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
121.522025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch+13 pts over 3 years
In 2025, the liquidity ratio of GRANDE PHARMACIE RAMBERTOISE (121.52) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of GRANDE PHARMACIE RAMBERTOISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of GRANDE PHARMACIE RAMBERTOISE is estimated at
1 393 252 €
(range 945 467€ - 2 186 204€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
945k€1393k€2186k€
1 393 252 €Range: 945 467€ - 2 186 204€
NAF 5 année 2025
Valuation method used
Net Income Multiple
87 708 €
×
15.9x
=1 393 252 €
Range: 945 467€ - 2 186 204€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE RAMBERTOISE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE RAMBERTOISE
What is the revenue of GRANDE PHARMACIE RAMBERTOISE ?
The revenue of GRANDE PHARMACIE RAMBERTOISE is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE RAMBERTOISE profitable?
Yes, GRANDE PHARMACIE RAMBERTOISE generated a net profit of 88 k€ in 2025.
Where is the headquarters of GRANDE PHARMACIE RAMBERTOISE ?
The headquarters of GRANDE PHARMACIE RAMBERTOISE is located in SAINT-RAMBERT-D'ALBON (26140), in the department Drome.
Where to find the tax return of GRANDE PHARMACIE RAMBERTOISE ?
The tax return of GRANDE PHARMACIE RAMBERTOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE RAMBERTOISE operate?
GRANDE PHARMACIE RAMBERTOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart